These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1004068)

  • 1. [Smoking and lung neoplasms: Is more proof needed?].
    Carlens E
    Lakartidningen; 1976 Dec; 73(51):4513-4. PubMed ID: 1004068
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic factors in pulmonary neoplasms.
    Mulvihill JJ
    Birth Defects Orig Artic Ser; 1976; 12(1):99-111. PubMed ID: 990446
    [No Abstract]   [Full Text] [Related]  

  • 3. Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer.
    Yoshikawa M; Arashidani K; Kawamoto T; Kodama Y
    Environ Res; 1994 Apr; 65(1):1-11. PubMed ID: 8162876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Host factors in lung cancer].
    Yoneyama T
    Kokyu To Junkan; 1984 Oct; 32(10):988-1001. PubMed ID: 6395244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of cytochrome P4501A1 (CYP1A1) in lung cancer sensitivity].
    Kiyohara C
    Fukuoka Igaku Zasshi; 1996 Sep; 87(9):185-8. PubMed ID: 8964567
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cigarette smoking on aryl hydrocarbon hydroxylase activity in lungs and tissues of inbred mice.
    Abramson RK; Hutton JJ
    Cancer Res; 1975 Jan; 35(1):23-9. PubMed ID: 1109792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies].
    Vineis P; Landi MT; Caporaso N
    Med Lav; 1992; 83(6):557-75. PubMed ID: 1296137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allelic distribution of the CYP1A1 in lung cancer patients, middle-aged tissue donors and in elderly people without cancer].
    Belogubova EV; Togo AV; Suvorova IK; Karpova MB; Ulybina IuM; Zaĭtseva OA; Iatsuk OS; Shutkin VA; Riabokon' SA; Ievleva AG; Chekmarëva EV; Lemekhov VG; Koloskov AV; Kuchinskiĭ AP; Khanson KP; Imianitov EN
    Vopr Onkol; 2004; 50(2):165-8. PubMed ID: 15176217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
    Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
    Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic predisposition to lung cancer in smokers].
    Korsgaard R; Trell E; Simonsson BG; Svensson G; Lindén CJ
    Nord Med; 1985; 100(4):104-6, 110. PubMed ID: 3991344
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoking, oral and oropharyngeal cancer in relation to AHH-enzyme activity].
    Björlin G; Andréasson L; Trell E
    Tandlakartidningen; 1986 Jun; 78(11):602-5. PubMed ID: 3462944
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of aryl hydrocarbon hydroxylase activity in human primary lung carcinoma x mouse hepatoma somatic cell hybrids.
    Manjunath GS; Dufresne MJ
    Biochem Int; 1989 Aug; 19(2):413-20. PubMed ID: 2818604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking and lung cancer in Switzerland 1900-1973 (author's transl)].
    Gsell O
    Schweiz Rundsch Med Prax; 1975 May; 64(21):643-50. PubMed ID: 1144295
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the predisposition to lung cancer governed by genetic variability?
    Schmidt R
    Dtsch Med Wochenschr; 1974 Sep; 99(38):1887-8. PubMed ID: 4452306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Smoke and oncogenesis].
    Gravella E
    Minerva Med; 1982 Sep; 73(36):2349-56. PubMed ID: 7110616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of squamous metaplasia of the respiratory epithelium in relation to cigarette smoking. Cytological study of 1,000 apparently healthy male individuals].
    Maltoni C; Carretti D; Canepari C; Ghetti G
    Cancro; 1968; 21(4):349-56. PubMed ID: 5757649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.